Skip to main content
David Wilkes, MD, Pulmonology, Indianapolis, IN

DavidWilkesMD

Pulmonology Indianapolis, IN

Critical Care Medicine

Executive Associate Dean for Research Affairs

Dr. Wilkes is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Wilkes' full profile

Already have an account?

  • Office

    Indiana University School of Medicine 340 W 10th Street
    6200
    Indianapolis, IN 46202
    Phone+1 317-278-7020
    Fax+1 317-278-8439

Education & Training

  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 1989 - 1992
  • Temple University Hospital
    Temple University HospitalResidency, Internal Medicine, 1982 - 1985
  • Lewis Katz School of Medicine at Temple University
    Lewis Katz School of Medicine at Temple UniversityClass of 1982
  • Villanova University
    Villanova UniversityB.S., Biology, 1974 - 1978

Certifications & Licensure

  • VA State Medical License
    VA State Medical License 2016 - 2026
  • IN State Medical License
    IN State Medical License 1992 - 2023
  • TX State Medical License
    TX State Medical License 1986 - 1992
  • PA State Medical License
    PA State Medical License 1983 - 1986
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • Certificate of Excellence, Chancellor’s Academic Honors Convocation Indiana University Purdue University, 2015
  • President’s Medal Indiana University, 2015
  • Award for Advancements in Science and Technology Center for Leadership Development, 2014
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • The HMGB1-RAGE Inflammatory Pathway: Implications for Brain Injury Induced Pulmonary Dysfunction  
    Weber D., Y.M. Allette, D.S. Wilkes, F.A. White, Antioxidants & Redox Signaling, 1/1/2015
  • Objective Estimates Improve Risk Stratification for Primary Graft Dysfunction after Lung Transplantation  
    Shah RJ, J.M. Diamond, E. Cant, J. Flesch, J.C. Lee, D.J. Lederer, V.N. Lama, J. Orens, A. Weinacker, D.S. Wilkes, D. Roe, S. Bhorade, K.M. Wille, L.B. Ware, S.M. Pa..., Am J Transplant, 1/1/2015
  • Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis  
    LEAD AUTHORS: Martinez, F.J., deAndrade, J., Anstrom K.J., King, T.E., Raghu G. COLLABORATORS: Martinez FJ, Raghu G, Schwarz M, Toews GB, Hunninghake G, Zibrak J, Deme..., N Engl J Med, 1/1/2014
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Lectures

  • Autoimmunity post transplant: Is this simply an immune memory response? 
    Vail, CO - 1/1/2015
  • Emerging concepts in innate and adaptive immunity in airway fibrogenesis post lung transplantation. 
    Vail, CO - 1/1/2015
  • A Career in Academic Medicine – One Man’s Journey 
    1/1/2015
  • Join now to see all

Other

  • Lung Transplantation (interview for “Sound Medicine”) 
    Wilkes D, National Public Radio
    1/1/2005
  • Videotape – NIH T35 Summer Research Program 
    D.S. Wilkes - Executive Producer
    1/1/2000
  • Smoking & Pregnancy - Invited guest 
    Wilkes D, Channel 13 News
    1/1/1995
  • Join now to see all

Press Mentions

  • Dr. David S. Wilkes Appointed to Syneos Health Board of Directors
    Dr. David S. Wilkes Appointed to Syneos Health Board of DirectorsJune 16th, 2021
  • Melina R. Kibbe Named Dean of UVA School of Medicine
    Melina R. Kibbe Named Dean of UVA School of MedicineJune 9th, 2021
  • U.Va. Names New Medical School Dean
    U.Va. Names New Medical School DeanJune 9th, 2021
  • Join now to see all

Grant Support

  • IU Training Prog. In Molecular Physiology And Clinical Mechanisms Of Lung DiseaseNational Heart, Lung, And Blood Institute2009–2012
  • TH17 Autoimmunity To Type V Collagen In Heart And Lung TransplantNational Institute Of Allergy And Infectious Diseases2010–2011
  • IL-17A And Anti-Col (V) Humoral Immunity In Lung Allograft RejectionNational Institute Of Allergy And Infectious Diseases2010–2011
  • Administrative CoreNational Institute Of Allergy And Infectious Diseases2010–2011
  • Role Of Anti-Col (V) Immunity In Primary Graft DysfunctionNational Heart, Lung, And Blood Institute2010–2011
  • Type V Collagen Prevents Lung Allograft RejectionNational Heart, Lung, And Blood Institute2001–2011
  • MMPS In Alloimmune And Autoimmune Lung DiseaseNational Heart, Lung, And Blood Institute2005–2008
  • Immune Responses In Lung Allograft RejectionNational Heart, Lung, And Blood Institute1999–2006
  • Innovative Methods For Immune Tolerance In Lung Transpl*National Heart, Lung, And Blood Institute2001–2003
  • Short-Term Training For Minority StudentsNational Heart, Lung, And Blood Institute1999–2003
  • Accessory Cells In Lung Allograft RejectionNational Heart, Lung, And Blood Institute1997–2000
  • Accessory Cells And Lung Allograft RejectionNational Heart, Lung, And Blood Institute1996
  • Role Of Type V Collagen In Lung Allograft RejectionNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1995–1996
  • Regulation Of B Cells In Human LungNational Center For Research Resources1995